Anthrax Anti-toxin Said Effective; Disinfection System Gets Patent
Looks like there might be government funding available for some of this type of research. Wonder if Medizone ever attempted to apply for it.
ETI-204 was granted “fast track” status and Orphan Drug Designation by the Food and Drug Administration. The program is supported with federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority (BARDA), the Department of Health and Human Services (HHS)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.